Published in Cancer Res on March 15, 1999
Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy. EMBO J (2002) 2.17
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol (2013) 1.62
Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther (2009) 1.55
Current approaches and future directions in the treatment of HER2-positive breast cancer. Cancer Treat Rev (2012) 1.23
Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines. J Cancer Res Clin Oncol (2005) 1.11
Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer. Int J Breast Cancer (2011) 1.10
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer. Invest New Drugs (2005) 1.08
Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer. Br J Cancer (2002) 1.06
Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells. Breast Cancer Res (2005) 1.05
Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells. Br J Cancer (2009) 1.02
HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer. Anticancer Res (2007) 0.96
Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma. Br J Cancer (2009) 0.94
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer (2004) 0.94
Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. Breast Cancer Res (2006) 0.93
Breast cancer subtypes: response to radiotherapy and potential radiosensitisation. Br J Radiol (2013) 0.90
Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Radiol Oncol (2014) 0.88
Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990. Radiat Oncol (2013) 0.88
Antiangiogenic Steroids in Human Cancer Therapy. Evid Based Complement Alternat Med (2005) 0.87
Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society. J Cancer Res Clin Oncol (2013) 0.87
Crystalline monoclonal antibodies for subcutaneous delivery. Proc Natl Acad Sci U S A (2003) 0.86
A bioinformatics filtering strategy for identifying radiation response biomarker candidates. PLoS One (2012) 0.86
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radiol Oncol (2014) 0.85
Immune effects of trastuzumab. J Cancer (2011) 0.84
Trastuzumab in the management of early and advanced stage breast cancer. Biologics (2007) 0.84
Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider. Oncologist (2010) 0.83
Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer. Crit Rev Oncol Hematol (2010) 0.83
STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers. Oncotarget (2016) 0.80
Association of Human Epidermal Growth Factor Receptor 2 with Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer. J Breast Cancer (2013) 0.80
Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference? Br J Cancer (2003) 0.80
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines. Invest New Drugs (2011) 0.78
Immunological Approaches in the Treatment of Metastasized Breast Cancer. Breast Care (Basel) (2009) 0.77
Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab. Oncologist (2015) 0.76
Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology. Radiat Oncol (2010) 0.76
Reversion of the ErbB malignant phenotype and the DNA damage response. Exp Mol Pathol (2012) 0.76
Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy. Rep Pract Oncol Radiother (2017) 0.75
Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy. Medicine (Baltimore) (2016) 0.75
Molecular Subtypes and Local-Regional Control of Breast Cancer. Surg Oncol Clin N Am (2018) 0.75
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol (1999) 11.78
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J (1998) 7.39
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A (1987) 5.65
Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med (2000) 4.99
Expression of cellular oncogenes in human malignancies. Science (1984) 4.48
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol (1997) 3.66
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol (2000) 3.56
Angiosarcoma. A report of 67 patients and a review of the literature. Cancer (1996) 3.48
Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science (1984) 3.39
Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene (1996) 3.33
Glass fiber contamination of cigarette filters: an additional health risk to the smoker? Cancer Epidemiol Biomarkers Prev (1998) 3.15
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res (1994) 3.03
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet (1999) 2.83
Urachal remnant diseases: spectrum of CT and US findings. Radiographics (2001) 2.82
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol (2001) 2.80
Prognostic classification of breast ductal carcinoma-in-situ. Lancet (1995) 2.70
Structure of a cephalosporin synthase. Nature (1998) 2.59
Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene (1990) 2.50
The x gene is essential for HTLV replication. Science (1985) 2.44
Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43
Enzymic parameters: measurement of V and Km. Biochim Biophys Acta (1971) 2.42
Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science (1988) 2.31
Abietadiene synthase from grand fir (Abies grandis): characterization and mechanism of action of the "pseudomature" recombinant enzyme. Biochemistry (2000) 2.31
Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol (2001) 2.22
Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity (1999) 2.21
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VII. Mapping the ribosomal RNA genes of plasmid F14. J Mol Biol (1974) 2.18
Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol (1983) 2.14
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. IV. The F sequences in F14. J Mol Biol (1974) 2.11
Studies of the human c-myb gene and its product in human acute leukemias. Science (1986) 2.10
Retracted New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. Proc Natl Acad Sci U S A (1998) 2.05
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene (1998) 1.98
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene (1994) 1.88
Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr (1995) 1.81
Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene (1997) 1.78
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol (2000) 1.77
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Regulation of expression of human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.76
Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J Neurosci (2001) 1.75
Creation and diagnosis of a solid-density plasma with an X-ray free-electron laser. Nature (2012) 1.74
Spread of the Spanish multi-resistant serotype 23F clone of Streptococcus pneumoniae to Seoul, Korea. Microb Drug Resist (1997) 1.74
Absolute pulse energy measurements of soft x-rays at the Linac Coherent Light Source. Opt Express (2014) 1.73
Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res (2007) 1.72
HER-2/neu as a predictive marker of response to breast cancer therapy. Breast Cancer Res Treat (1998) 1.69
High prevalence of Gymnophalloides seoi infection in a village on a southwestern island of the Republic of Korea. Am J Trop Med Hyg (1994) 1.68
Expression of cellular oncogenes during embryonic and fetal development of the mouse. Proc Natl Acad Sci U S A (1984) 1.68
Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy. AJR Am J Roentgenol (2001) 1.68
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. V. ilv+ Deletion mutants of F14. J Mol Biol (1974) 1.68
Studies of the putative transforming protein of the type I human T-cell leukemia virus. Science (1985) 1.65
Folate intake and the risk of colorectal cancer in a Korean population. Eur J Clin Nutr (2009) 1.65
Nephropathy of secondary syphilis. A clinical and pathological spectrum. JAMA (1971) 1.63
First-line Herceptin monotherapy in metastatic breast cancer. Oncology (2001) 1.60
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. IX. Note on the deletion mutant of F, F delta(33-43). J Mol Biol (1974) 1.60
Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis. Clin Infect Dis (2001) 1.58
Identification and characterization of the protein encoded by the human N-myc oncogene. Science (1986) 1.58
Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: identification of 14 novel mutations. Thromb Haemost (2001) 1.55
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VIII. The structure of bacteriophage phi 80d-3ilv+su+7, including the mapping of the ribosomal RNA genes. J Mol Biol (1974) 1.54
Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas. J Biol Chem (1996) 1.53
Actinomycete infections in humans--a review. Gene (1992) 1.53
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens. Proc Natl Acad Sci U S A (1985) 1.51
Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int (2011) 1.51
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br J Cancer (2013) 1.50
HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells (1997) 1.49
Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation (2001) 1.48
Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis (2001) 1.46
GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin Immunol (1999) 1.46
Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. J Mol Biol (1992) 1.44
Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand (1999) 1.44
Expression pattern of germ cell-specific genes in the testis of patients with nonobstructive azoospermia: usefulness as a molecular marker to predict the presence of testicular sperm. Fertil Steril (2000) 1.44
Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol (2012) 1.44
Abdominal actinomycosis: CT findings in 10 patients. AJR Am J Roentgenol (1993) 1.43
Peritoneal inclusion cysts and their relationship to the ovaries: evaluation with sonography. Radiology (1997) 1.43
The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. Cancer Treat Res (2000) 1.43
A case of Dowling-Degos disease suggesting an evolutional sequence. J Dermatol (2000) 1.42
Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology (2001) 1.41
The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J Comp Neurol (1987) 1.41
HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes. Science (1988) 1.41
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Br J Cancer (2009) 1.41
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia (2004) 1.39
Characteristic radiographic features of the central ray in Apert syndrome. J Hand Surg Eur Vol (2012) 1.39
Arrangement of the systemic and pulmonary venous components of the atrial chambers in hearts with isomeric atrial appendages. Cardiol Young (2000) 1.39
Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain (2001) 1.39
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene (1999) 1.39
FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene (2012) 1.39
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. VI. Mapping of F14 sequences homologous to phi 80dmetBJF and phi 80dargECBH bacteriophages. J Mol Biol (1974) 1.38
Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene (1993) 1.38
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol (2006) 1.37
Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer (1990) 1.36
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene (1997) 1.35
Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene (1995) 1.34
Neurogenesis in a rat model of age-related cognitive decline. Aging Cell (2004) 1.33
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol (2001) 1.32
Treatment of meningeal breast cancer xenografts in the rat using an anti-p185/HER2 antibody. Clin Cancer Res (2001) 1.31